Saturday, July 27, 2024 12:25:38 PM
Recent CRNX News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:08:00 PM
- Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 10/10/2024 08:40:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 09:13:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/09/2024 08:35:30 PM
- Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock • GlobeNewswire Inc. • 10/09/2024 03:55:11 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/08/2024 09:01:03 PM
- Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 10/08/2024 08:01:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/07/2024 11:55:43 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/03/2024 08:08:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 09:01:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:23:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/26/2024 08:06:32 PM
- Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly • GlobeNewswire Inc. • 09/26/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:05:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 08:30:03 PM
- Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/10/2024 08:40:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/10/2024 04:11:28 PM
- Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 08/29/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 08:31:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/26/2024 05:16:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:30:04 PM
- Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/12/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/12/2024 03:35:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:13:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:10:13 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM